Literature DB >> 2984585

Studies on the mechanism of clonidine-induced mydriasis in the rat.

J A Hey, T Gherezghiher, M C Koss.   

Abstract

Intravenous administration of clonidine hydrochloride (3-100 micrograms/kg) produced a dose-dependent pupillary dilation in anaesthetized rats. All experiments were carried out in rats in which vagosympathetic nerve trunks were sectioned bilaterally at the cervical level. Clonidine-induced mydriasis was present only in those preparations having intact parasympathetic neural tone to the iris. Depletion of CNS monoamines by more than 95% with reserpine (5 mg/kg) and alpha-methyl-para-tyrosine (2 X 300 mg/kg) failed to alter the dose-response relation to clonidine. Pretreatment with the alpha-2-adrenoceptor antagonist, yohimbine hydrochloride (1.5 mg/kg), produced about a 10-fold shift to the right in the pupillary dose-response curve to clonidine. Yohimbine administered after the highest dose of clonidine also antagonized the mydriatic response. The above results suggest that clonidine acts on CNS post-synaptic alpha-2-adrenoceptors to produce mydriasis by withdrawal of parasympathetic neural tone to the iris. In an attempt to assess the physiological substrate(s) involved, mydriatic responses, due to parasympatho-inhibition, were evoked by electrical stimulation of ascending (sciatic nerve and medullary) and descending (hypothalamic) pathways. Yohimbine (0.3 and 1.0 mg/kg) produced a dose-dependent inhibition of the pupillary dilation evoked by stimulation of the sciatic nerve and medullary loci, whereas these doses of yohimbine failed to alter the dilation in response to hypothalamic stimulation. Similarly, monoamine depletion greatly antagonized the pupillary dilation elicited by sciatic nerve and medullary stimulation without significantly affecting mydriasis due to hypothalamic stimulation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2984585     DOI: 10.1007/bf00515551

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  25 in total

1.  ADRENERGIC MECHANISMS IN THE PUPILLARY LIGHT-REFLEX PATH.

Authors:  A DAHLSTROEM; K FUXE; N A HILLARP; T MALMFORS
Journal:  Acta Physiol Scand       Date:  1964 Sep-Oct

2.  On dilatation of the pupil from stimulation of the cortex cerebri.

Authors:  J H Parsons
Journal:  J Physiol       Date:  1901-04-24       Impact factor: 5.182

3.  Analysis of clonidine-induced mydriasis.

Authors:  M C Koss; L C San
Journal:  Invest Ophthalmol       Date:  1976-07

4.  The variability of the interaural line vs the stability of bregma in rat stereotaxic surgery.

Authors:  I Q Whishaw; J D Cioe; N Previsich; B Kolb
Journal:  Physiol Behav       Date:  1977-12

5.  Inhibition of sympathetic preganglionic neurons by catecholamines and clonidine: mediation by an alpha-adrenergic receptor.

Authors:  P G Guyenet; J B Cabot
Journal:  J Neurosci       Date:  1981-08       Impact factor: 6.167

6.  An excitatory action 0f 5-hydroxytryptamine on sympathetic preganglionic neurones.

Authors:  W C De Groat; R W Ryall
Journal:  Exp Brain Res       Date:  1967       Impact factor: 1.972

7.  Methyldopa produces central inhibition of parasympathetic activity in the cat.

Authors:  M C Koss
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-11       Impact factor: 3.000

8.  Susceptibility of spontaneous sympathetic outflow and sympathetic reflexes to depression by clonidine.

Authors:  T Baum; A T Shropshire
Journal:  Eur J Pharmacol       Date:  1977-07-15       Impact factor: 4.432

9.  Differential sensitivity of four central sympathetic pathways to depression by clonidine.

Authors:  D N Franz; P W Madsen
Journal:  Eur J Pharmacol       Date:  1982-02-19       Impact factor: 4.432

10.  Studies on the mechanism of methyl-dopa-induced mydriasis in the cat.

Authors:  T Gherezghiher; H D Christensen; M C Koss
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-07       Impact factor: 3.000

View more
  10 in total

1.  alpha-Methyldopa produces mydriasis in the rat by stimulation of CNS alpha 2-adrenoceptors.

Authors:  J A Hey; T Ito; M C Koss
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

2.  Modulation by antidepressant drugs of CNS postsynaptic alpha 2-adrenoceptors mediating mydriasis in the rat.

Authors:  A Menargues; R Obach; J A García-Sevilla
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990 Jan-Feb       Impact factor: 3.000

3.  Behavioural and physiological effects induced by an infusion of antisense to alpha(2D)-adrenoceptors in the rat.

Authors:  E S Robinson; D J Nutt; H C Jackson; A L Hudson
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

4.  Mechanism of dexamphetamine-induced mydriasis in the anaesthetized rat.

Authors:  J A Hey; T Ito; M C Koss
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

5.  The relative potencies of cholinomimetics and muscarinic antagonists on the rat iris in vivo: effects of pH on potency of pirenzepine and telenzepine.

Authors:  J J Hagan; B van der Heijden; C L Broekkamp
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

6.  Effects of antidepressant drugs and electroconvulsive shock on pre- and postsynaptic alpha 2-adrenoceptor function in the brain: rapid down-regulation by sibutramine hydrochloride.

Authors:  D J Heal; M R Prow; W R Buckett
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

7.  Evidence for altered alpha 2-adrenoceptor function following isolation-rearing in the rat.

Authors:  A J Fulford; S Butler; D J Heal; D A Kendall; C A Marsden
Journal:  Psychopharmacology (Berl)       Date:  1994-10       Impact factor: 4.530

8.  Are Alpha-2D Adrenoceptor Subtypes Involved in Rat Mydriasis Evoked by New Imidazoline Derivatives: Marsanidine and 7-Methylmarsanidine?

Authors:  Joanna Raczak-Gutknecht; Teresa Frąckowiak; Antoni Nasal; Anita Kornicka; Franciszek Sączewski; Roman Kaliszan
Journal:  Dose Response       Date:  2017-04-18       Impact factor: 2.658

9.  Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans.

Authors:  E R Samuels; E Szabadi
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

10.  Modulation of physiological reflexes by pain: role of the locus coeruleus.

Authors:  Elemer Szabadi
Journal:  Front Integr Neurosci       Date:  2012-10-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.